Benefit finding, posttraumatic growth and health-related quality of life in long-term cancer survivors: a prospective population-based study.


Journal

Acta oncologica (Stockholm, Sweden)
ISSN: 1651-226X
Titre abrégé: Acta Oncol
Pays: England
ID NLM: 8709065

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 28 9 2023
pubmed: 18 8 2023
entrez: 18 8 2023
Statut: ppublish

Résumé

We explored the relationship between benefit finding (BF)/posttraumatic growth (PTG) at baseline and health-related quality of life (HRQOL) at baseline and follow-up in long-term cancer survivors (LTCS; ≥5-year post-diagnosis). HRQOL was assessed in LTCS in 2009-2011 (5- to 16-year post-diagnosis, baseline) and re-assessed in 2018/2019 (14- to 24-year post-diagnosis, follow-up). BF and PTG were measured at baseline; mean scores were dichotomized into 'none-to-low' (<3) and 'moderate-to-high' (> =3). Linear regression models and linear mixed regression models were employed to assess the association of BF/PTG with HRQOL. Of the 6057 baseline participants, 4373 were alive in 2019, of whom 2704 completed the follow-up questionnaire. Cross-sectionally, LTCS with none-to-low BF reported better HRQOL at baseline and at follow-up than LTCS with higher BF. Longitudinally, no difference was found between none-to-low and moderate-to-high BF on the HRQOL change from baseline to follow-up. HRQOL differences between the PTG groups were not statistically significant cross-sectionally and longitudinally, except those participants with moderate-to-high PTG reported higher role functioning and global health status/QOL. Cross-sectionally, BF was significantly negatively related to subscales of HRQOL, while PTG was positively correlated to role functioning and global health status/QOL. The results add further evidence that BF and PTG are two different positive psychological concepts.

Sections du résumé

BACKGROUND UNASSIGNED
We explored the relationship between benefit finding (BF)/posttraumatic growth (PTG) at baseline and health-related quality of life (HRQOL) at baseline and follow-up in long-term cancer survivors (LTCS; ≥5-year post-diagnosis).
MATERIALS AND METHODS UNASSIGNED
HRQOL was assessed in LTCS in 2009-2011 (5- to 16-year post-diagnosis, baseline) and re-assessed in 2018/2019 (14- to 24-year post-diagnosis, follow-up). BF and PTG were measured at baseline; mean scores were dichotomized into 'none-to-low' (<3) and 'moderate-to-high' (> =3). Linear regression models and linear mixed regression models were employed to assess the association of BF/PTG with HRQOL.
RESULTS UNASSIGNED
Of the 6057 baseline participants, 4373 were alive in 2019, of whom 2704 completed the follow-up questionnaire. Cross-sectionally, LTCS with none-to-low BF reported better HRQOL at baseline and at follow-up than LTCS with higher BF. Longitudinally, no difference was found between none-to-low and moderate-to-high BF on the HRQOL change from baseline to follow-up. HRQOL differences between the PTG groups were not statistically significant cross-sectionally and longitudinally, except those participants with moderate-to-high PTG reported higher role functioning and global health status/QOL.
CONCLUSIONS UNASSIGNED
Cross-sectionally, BF was significantly negatively related to subscales of HRQOL, while PTG was positively correlated to role functioning and global health status/QOL. The results add further evidence that BF and PTG are two different positive psychological concepts.

Identifiants

pubmed: 37594165
doi: 10.1080/0284186X.2023.2245560
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1124-1131

Auteurs

Zhunzhun Liu (Z)

Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Medical Faculty of Heidelberg, University of Heidelberg, Heidelberg, Germany.

Melissa S Y Thong (MSY)

Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Daniela Doege (D)

Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Lena Koch-Gallenkamp (L)

Division of Clinical Epidemiology and Aging Research, DKFZ, Heidelberg, Germany.

Linda Weisser (L)

Medical Faculty of Heidelberg, University of Heidelberg, Heidelberg, Germany.
Division of Clinical Epidemiology and Aging Research, DKFZ, Heidelberg, Germany.

Heike Bertram (H)

Cancer Registry of North Rhine-Westphalia, Bochum, Germany.

Andrea Eberle (A)

Bremen Cancer Registry, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.

Bernd Holleczek (B)

Saarland Cancer Registry, Saarbrücken, Germany.

Alice Nennecke (A)

Hamburg Cancer Registry, Hamburg, Germany.

Annika Waldmann (A)

Institute of Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany.

Sylke Ruth Zeissig (SR)

Cancer Registry Rhineland-Palatinate, Mainz, Germany.
Institute of Clinical Epidemiology and Biometry (ICE-B), Julius Maximilian University of Wuerzburg, Würzburg, Germany.

Ron Pritzkuleit (R)

Cancer Registry of Schleswig-Holstein, Lübeck, Germany.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research, DKFZ, Heidelberg, Germany.
Division of Preventive Oncology, DKFZ and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
German Cancer Consortium (DKTK), DKFZ, Heidelberg, Germany.

Volker Arndt (V)

Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH